Company Filing History:
Years Active: 2022
Title: Mark Daley - Innovator in Metabolomics Profiling for CNS Injuries
Introduction
Mark Daley is a notable inventor based in London, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the area of central nervous system (CNS) injuries. His innovative approach utilizes metabolomics to enhance the diagnosis of various CNS injuries, including acquired brain injury and spinal cord injury.
Latest Patents
Mark Daley holds a patent for a groundbreaking method titled "Metabolomics profiling of central nervous system injury." This patent outlines a method for diagnosing CNS injuries such as acquired brain injury (ABI) and acquired spinal cord injury (ASI). The method involves obtaining a biological test sample from the subject, identifying metabolites using metabolomics, and generating a subject's profile. By employing multivariate statistical analysis and machine learning, the method compares the subject's profile with predetermined profiles of CNS injuries and controls to determine the presence of a CNS injury. Mark Daley has 1 patent to his name.
Career Highlights
Mark Daley is affiliated with the London Health Sciences Centre Research Inc., where he continues to advance research in the field of metabolomics and CNS injuries. His work is pivotal in improving diagnostic methods, which can lead to better patient outcomes.
Collaborations
Some of Mark Daley's notable coworkers include Douglas Dale Fraser and Robert Bartha. Their collaborative efforts contribute to the ongoing research and development in the field of CNS injury diagnostics.
Conclusion
Mark Daley's innovative work in metabolomics profiling represents a significant advancement in the diagnosis of central nervous system injuries. His contributions are essential for enhancing medical diagnostics and improving patient care.